Literature DB >> 24496929

α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.

Masaoki Ito1, Man Hagiyama, Takahiro Mimae, Takao Inoue, Takashi Kato, Azusa Yoneshige, Jun Nakanishi, Tadashi Kondo, Morihito Okada, Akihiko Ito.   

Abstract

Invasive lobular carcinoma (ILC) is more frequently lymph node positive than is invasive ductal carcinoma (IDC), and ILC cell infiltration shows distinctive histological characteristics, suggesting the action of ILC-specific invasion molecules. To identify such a molecule, we used a proteomic approach in the pseudopodia of MDA-MB-231 breast cancer cells. A pseudopodial constituent was identified using excimer laser ablation, two-dimensional difference gel electrophoresis, mass spectroscopy, and immunocytofluorescence. MDA-MB-231 cells were modified to express various levels of this constituent by transient transfection and were examined for pseudopodia formation and migratory abilities using wound healing and two-chamber assays. Immunohistochemical positivity of human breast cancer cells (56 ILCs and 21 IDCs) was compared with clinicopathological variables. An actin-binding adaptor protein, α-parvin, was found to localize to pseudopodia and to form focal adhesions in cells not induced to extend pseudopodia. Pseudopodial length and density and migratory abilities correlated with α-parvin expression. Twenty-one (37.5 %) ILCs stained positive for α-parvin, whereas the results were negative for all 21 IDCs (P < 0.001). α-Parvin positivity in ILC was significantly associated with lymphatic invasion (P = 0.038) and lymph node metastasis (P = 0.003) in univariate analyses and to lymph node metastasis (P = 0.020) in multivariate analyses. α-Parvin, a pseudopodial constituent, was found to promote migration of breast cancer cells and to be expressed exclusively by ILC, suggesting that α-parvin is an ILC-specific invasion molecule that may have clinical utility as a biomarker for aggressive subsets of ILC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496929     DOI: 10.1007/s10549-014-2859-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  α-Parvin and β-parvin in the rat uterus during decidualisation and uterine receptivity.

Authors:  Leigh Nicholson; Romanthi Madawala; Laura Lindsay; Christopher R Murphy
Journal:  Histochem Cell Biol       Date:  2018-12-05       Impact factor: 4.304

2.  α-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.

Authors:  Ying Sun; Yanyan Ding; Chen Guo; Chengmin Liu; Ping Ma; Shuang Ma; Zhe Wang; Jie Liu; Tao Qian; Luyao Ma; Yi Deng; Chuanyue Wu
Journal:  Oncogene       Date:  2019-02-25       Impact factor: 9.867

3.  Cell Adhesion Molecule 1 Contributes to Cell Survival in Crowded Epithelial Monolayers.

Authors:  Man Hagiyama; Ryuichiro Kimura; Azusa Yoneshige; Takao Inoue; Tomoyuki Otani; Akihiko Ito
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

4.  Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).

Authors:  Vasiliki Gkretsi; Maria Louca; Andreas Stylianou; George Minadakis; George M Spyrou; Triantafyllos Stylianopoulos
Journal:  Int J Mol Sci       Date:  2019-01-04       Impact factor: 5.923

5.  MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.

Authors:  Tong Liu; Kebang Hu; Zuowei Zhao; Guanglei Chen; Xunyan Ou; Hao Zhang; Xin Zhang; Xiaofei Wei; Dan Wang; Meizi Cui; Caigang Liu
Journal:  Oncotarget       Date:  2015-12-08

6.  A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.

Authors:  Guermarie Velazquez-Torres; Einav Shoshan; Cristina Ivan; Li Huang; Enrique Fuentes-Mattei; Harrison Paret; Sun Jin Kim; Cristian Rodriguez-Aguayo; Victoria Xie; Denise Brooks; Steven J M Jones; A Gordon Robertson; George Calin; Gabriel Lopez-Berenstein; Anil Sood; Menashe Bar-Eli
Journal:  Nat Commun       Date:  2018-01-31       Impact factor: 14.919

7.  High PINCH1 Expression in Human Laryngeal Carcinoma Associates with Poor Prognosis.

Authors:  Georgios Tsinias; Sofia Nikou; Theodoros Papadas; Panagiotis Pitsos; Helen Papadaki; Vasiliki Bravou
Journal:  Anal Cell Pathol (Amst)       Date:  2018-03-20       Impact factor: 2.916

8.  Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer.

Authors:  Yoshie Kobayashi; Takayuki Kadoya; Ai Amioka; Hideaki Hanaki; Shinsuke Sasada; Norio Masumoto; Hideki Yamamoto; Koji Arihiro; Akira Kikuchi; Morihito Okada
Journal:  Oncotarget       Date:  2018-04-20

Review 9.  Ras Suppressor-1 (RSU1) in Cancer Cell Metastasis: A Tale of a Tumor Suppressor.

Authors:  Maria Louca; Triantafyllos Stylianopoulos; Vasiliki Gkretsi
Journal:  Int J Mol Sci       Date:  2020-06-07       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.